insights_auto
Why is QDEL up 8.14%?
Dive Deeperchevron_right
QDEL:NASDAQ
Quidelortho Corp
$13.42
arrow_upward
+8.14%(+1.01) 1D
$13.25
arrow_downward
-1.24% (-0.17)bedtimeAfter hours
Closed: Oct 9, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for QDEL...
Open
$12.52
High
$13.62
Low
$12.21
Mkt. cap
920.28M
Avg. vol.
1.59M
Volume
3.58M
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.79
Shares outstanding
68.58M
No. of employees
6K
Open
$12.52
High
$13.62
Low
$12.21
Mkt. cap
920.28M
Avg. vol.
1.59M
Volume
3.58M
52-wk high
$35.58
52-wk low
$9.92
EPS
-$15.40
Beta
0.79
Shares outstanding
68.58M
No. of employees
6K
News stories
From web sources and news partners
AD HOC NEWS
·
1 day ago
QuidelOrtho appoints Sanjeev Sharma. QuidelOrtho stock sits 65.12 percent below its high
Financial Times
·
2 days ago
QuidelOrtho Appoints Sanjeev Sharma as Vice President of Investor Relations – Company Announcement
Profile
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
On May 8, 2020 the U.S. Food and Drug Administration issued to Quidel the first emergency use authorization for a COVID-19 rapid antigen test, a new category of tests for use in the ongoing pandemic. These diagnostic tests quickly detect fragments of proteins found on or within the virus by testing samples collected from the nasal cavity using swabs. Wikipedia
About Quidelortho Corp
CEODouglas C Bryant
Employees6.5K
Founded1979
HeadquartersSan Diego, California, United States
SectorMedical device
Websitequidelortho.com